Company intelligence / Profile preview

RIVANNA

Charlottesville, Virginia, United Statesrivanna.org ↗

Ownership: Private
Employees: ~23
Development stage: Commercial

Overview

RIVANNA has commercialized the FDA-cleared Accuro ultrasound-guided spinal navigation device used in over 200 hospitals worldwide. The company’s next-generation AI-enabled musculoskeletal imaging system, Accuro XV, entered feasibility clinical trials in late 2024 to assess its safety and workflow integration in emergency departments. Early results highlight improved precision in fracture and soft-tissue injury assessment compared to traditional X-ray. The company has received significant BARDA funding to advance these technologies toward broader regulatory clearance.

Therapeutic areas: OtherRheumatologyNeurology
Modalities: Device (specifically ultrasound-based imaging devices)AI-enabled software for diagnostic imaging
Industry: Medical Imaging

Partnerships

BARDA (Biomedical Advanced Research and Development Authority) – major funding partner supporting development of advanced diagnostic systems.

Beyond the preview

Go deeper on RIVANNA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RIVANNA.

Explore the full profile